Dayer, Victoria W.; Drummond, Michael F.; Dabbous, Omar; Toumi, Mondher; Neumann, Peter; Tunis, Sean; Teich, Nelson; Saleh, Shadi; Persson, Ulf; Schulenburg, Johann-Matthias Graf von der; Malone, Daniel C.; Salimullah, Tay; Sullivan, Sean D.
(London : BioMed Central, 2024)
Health technology assessment (HTA) decisions for pharmaceuticals are complex and evolving. New rare disease treatments are often approved more quickly through accelerated approval schemes, creating more uncertainties about ...